Description of Analgesics – PST04211 Basic Pharmacology
NTA Level 4 • Semester 2 • PST04211 Description of Analgesics Basic Pharmacology • Source Session/Topic 18 Full source-text version: all educational wording from the extracted learning source is retained; only presenter/tutor metadata and web-layout noise are removed, while formatting is improved for readability. Session 18: Description of Analgesics Total Session Time: 120 minutes Prerequisites • None Learning Tasks By the end of this session students are expected to be able to: • List indications of analgesics • List contraindication of analgesics • Describe dose, dosage and course of analgesics • List side effects and adverse effects of analgesics • Describe interaction and precaution of analgesics Resources Needed: • Flip charts, marker pens, and masking tape • Black/white board and chalk/whiteboard markers • Computer and overhead projector SESSION OVERVIEW Activity/ Step Time Content Method 1 05 minutes Presentation Introduction, Learning Objectives Presentation/ 2 20 minutes Indications of Analgesics Buzzing Presentation/ 3 20 minutes Contraindication of Analgesics brainstorming 4 30 minutes Presentation Dose, Dosage and Course of Analgesics Presentation/ Side Effects and Adverse Effects of 5 20 minutes brainstorming Analgesics Description of Interaction and Precaution of 6 15 minutes Presentation Analgesics 7 05 minutes Presentation Key Points 8 05 minutes Presentation Evaluation PST 04211 Basic Pharmacology NTA Level 4 Semester 2 Facilitator Guide 107 SESSION CONTENTS STEP 1: Presentation of Session Title and Learning tasks (5 minutes) READ or ASK students to read the learning objectives and clarify ASK students if they have any questions before continuing. STEP 2: Indications of analgesics (20 minutes) Activity: Buzzing (5 minutes) ASK students to pair up and buzz on the following question for 2 minutes • What are the indications of analgesics? ALLOW few pairs to respond and let other pairs add on points not mentioned WRITE their response on the flip chart/board CLARIFY and SUMMARIZE by using the content below • Most drugs which have analgesic properties are also anti inflammatory and antipyretics; they include; Paracetamol, Aspirin and Others are Diclofenac, Ibuprofen, indomethacin, Piroxicam, Mefenamic acid and Naproxen • Narcotic analgesics like tramadol are used in the management of pain only, have no antiiflammatory or antppyretic effects • They are used in management of pain, fever and inflammation o Paracetamol and aspirin are used in management of pain and fever o Diclofenac, ibuprofen, indomethacin. Piroxicam, Mefenamic acid, and Naproxen are used in management of pain, fever and inflamation STEP 3: Contraindication of Analgesics (20 minutes) Activity: Brainstorming (5 minutes) Ask students to brainstorm on the following question: • What are the Contraindications of analgesics? ALLOW few students to respond WRITE their responses on the flip chart/ board CLARIFY and SUMMARISE by using the content below PST 04211 Basic Pharmacology NTA Level 4 Semester 2 Facilitator Guide 108 • Most individual drug which can be used as analgesic has different properties which make them to be contraindicated to patient with some conditions o Aspirin in children under 16 years and in breast-feeding due to Reye‘s syndrome, previous or active peptic ulceration and haemophilia o Diclofenac, ibuprofen, indomethacin, piroxicam, mefenamic acid, and naproxen are contra-indicated in patients with a history of hypersensitivity to aspirin or any other NSAID o Diclofenac, ibuprofen, indomethacin, piroxicam, mefenamic acid, and naproxen are contraindicated in severe heart failure and ischemic heart disease STEP 4: Dose, Dosage and Course of Analgesics (30 minutes) • Dose dosage and course of analgesics o Aspirin By mouth, 300–900 mg every 4–6 hours when necessary, maximum dose 4 g daily By rectum, 450–900 mg every 4 hours maximum dose 3.6 g daily) Intensive care, ADULT and CHILD over 1 month, by intravenous injection, initially 300–600 micrograms/kg then by intravenous infusion 4.5–29.5 micrograms/kg/minute Duration of the course should not exceed 5 days in case of pain and inflammation o Paracetamol By mouth, ADULT 0.5–1 g every 4–6 hours to a maximum dose. of 4 g daily CHILDREN 2 months 60 mg for post-immunisation pyrexia, repeated once after 6 hours if necessary CHILDREN 3 months–1 year 60–120 mg, 1–5 years 120–250 mg, 6–12 years 250–500 mg; these doses may be repeated every 4–6 hours when necessary (max. of 4 doses in 24 hours) By rectum, ADULT and CHILD over 12 years 0.5–1 g every 4–6 hours to a max. of 4 g daily; CHILD under 3 months Duration of the course should not exceed 3 days o Diclofenac By mouth, 75–150 mg daily in 2–3 divided doses By rectum in suppositories, 75–150 mg daily in 2-3 divided doses. Duration of the course should not exceed 5 days o Ibuprofen ADULT and CHILD over 12 years, initially 300–400 mg 3–4 times daily; increased if necessary to max. 2.4 g daily; maintenance dose of 0.6–1.2 g daily may be adequate Duration of the course should not exceed 5 days PST 04211 Basic Pharmacology NTA Level 4 Semester 2 Facilitator Guide 109 o Indomethacin By mouth, rheumatic disease, 50–200 mg daily in divided doses Acute gout, 150–200 mg daily in divided doses Dysmenorrhoea, up to 75 mg daily By rectum in suppositories, 100 mg at night and in dose 150–200 mg o Mefenamic acid CHILDREN 12–18 years, acute pain including dysmenorrhoea, ADULT over 18 years, 500 mg 3 times daily In menorrhagia, 500 mg 3 times daily Duration of the course should not exceed 5 days o Naproxen Acute musculoskeletal disorders and dysmenorrhoea, 500 mg initially, then 250 mg every 6–8 hours as required; maximum dose after first day 1.25 g daily. Duration of the course should not exceed 5 days o Piroxicam By mouth, rheumatic disease, initially 20 mg daily, increased if necessary to 30 mg daily in single or divided doses CHILD (6–18 years), juvenile idiopathic arthritis, under 15 kg, 5 mg daily; 16–25 kg, 10 mg; 26–45 kg, 15 mg; over 46 kg, 20 mg Duration of the course should not exceed 14 days o Indomethacin By